BDTX
Black Diamond Therapeutics, Inc.
Nasdaq Biological Products, (No Diagnostic Substances)
Emerging growth company

Key Financials

Operating Income
$12.5M
↑ 115.9%
Revenue
$0
NaN%
Net Income
$22.4M
↑ 132.1%
EPS (Diluted)
$0.39
↑ 130.7%
Total Liabilities
$30.8M
↓ 21.7%
Total Assets
$143.0M
↑ 16.6%
Shareholders' Equity
$112.2M
↑ 34.7%
Cash & Equivalents
$21.0M
↓ 42.4%

Recent SEC Filings

Form Type Filed Date Link
8-K 5/21/2026 View on SEC
10-Q 5/7/2026 View on SEC
8-K 5/7/2026 View on SEC
ARS 4/29/2026 View on SEC
DEFA14A 4/29/2026 View on SEC
DEF 14A 4/29/2026 View on SEC
4 3/20/2026 View on SEC
4 3/20/2026 View on SEC
S-8 3/16/2026 View on SEC
10-K 3/16/2026 View on SEC

Company Information

Field Value
Ticker BDTX
Company Name Black Diamond Therapeutics, Inc.
CIK 1701541
Sector Biological Products, (No Diagnostic Substances)
Industry
Emerging growth company
Exchange Nasdaq
SIC Code 2836
SIC Description Biological Products, (No Diagnostic Substances)
Entity Type operating
Fiscal Year End 1231
Phone 617-417-5868